Bax and Bcl-2 protein expression in gastric precancerous lesions: Immunohistochemical study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 11, 2005, Pages 1674-1678

  Anagnostopoulos, George K ^a,c   Stefanou, Dimitrios ^b   Arkoumani, Evdokia ^b   Sakorafas, George ^a   Pavlakis, George ^a   Arvanitidis, Dimitrios ^a   Tsianos, Epameinondas ^b   Agnantis, Niki J ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c Department of Oncology 251 Hellenic Air Force and Veterans General Hospital ^*  (Greece)

Author keywords

Apoptosis; Bax; Bcl 2; Gastric; Premalignant

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; ATROPHIC GASTRITIS; BAX GENE; BCL 2 GENE; CELL SURVIVAL; CHRONIC GASTRITIS; CONTROLLED STUDY; DYSPLASIA; EPITHELIUM CELL; FEMALE; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH BIOPSY; STOMACH CARCINOGENESIS; CHRONIC DISEASE; GASTRITIS; INTESTINE; METABOLISM; METAPLASIA; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; CHRONIC DISEASE; FEMALE; GASTRITIS; GASTRITIS, ATROPHIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS;

EID: 33644815778     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.04057.x     Document Type: Article

References (43)

1. Thompson GB, Van Heerden JA, Sarr MG. Adenocarcinoma of the stomach: are we making progress? Lancet 1993 342 : 713 18.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res. 1992 52 : 6735 40.
3. Wilson MR. Apoptosis: unmasking the executioner. Cell Death Differ. 1998 5 : 646 52.
4. Staunton MJ, Gaffney EF. Apoptosis: basic concepts and potential significance in human cancer. Arch. Pathol. Lab. Med. 1998 122 : 310 19.
5. Kuchino Y, Kitanaka C. Apoptosis in cancer. Hum. Cell 1996 9 : 223 8.
6. Szabo I, Tarnawski AS. Apoptosis in the gastric mucosa: molecular mechanisms, basic and clinical implications. J. Physiol. Pharmacol. 2000 51 : 3 15.
7. Von Herbay A, Rudy J. Role of apoptosis in gastric epithelial turnover. Microsc. Res. Tech. 2000 48 : 303 11.
8. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am. J. Gastroenterol. 2001 96 : 16 26.
9. Antonsson B. Bax and other pro-apoptotic Bcl-2 family killer-proteins and their victim, the mitochondrion. Cell Tissue Res. 2001 306 : 347 61.
10. Huang Z. Bcl-2 family proteins as targets for anticancer drug designs. Oncogene 2000 19 : 6627 31.
11. Price AB. The Sydney System: histological division. J. Gastroenterol. Hepatol. 2001 6 : 209 22.
12. Rugge M, Correa P, Dixon MF et al. Gastric dysplasia: the Padova international classification. Am. J. Surg. Pathol. 2000 24 : 167 76.
13. Koshida Y, Saegusa M, Okayasu I. Apoptosis, cell proliferation and expression of bcl-2 and bax in gastric carcinomas: immunohistochemical and clinicopathological study. Br. J. Cancer 1997 75 : 367 73.
14. Barinaga M. Apoptosis: life-death balance within the cell. Science 1996 274 : 724.
15. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998 281 : 1309 12.
16. Reed JC. Bcl-2 family proteins. Oncogene 1998 17 : 3225 36.
17. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993 174 : 609 19.
18. Antonsson B, Conti F, Ciavatta A et al. Inhibition of bax channel forming activity by Bcl-2. Science 1997 277 : 370 2.
19. McCurrach I, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 1997 94 : 2345 9.
20. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995 80 : 293 9.
21. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995 270 : 96 9.
22. Krajewski S, Blomqvist C, Franssila K et al. Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 1995 55 : 4471 8.
23. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 1997 385 : 637 40.
24. Bargou RC, Wagener C, Bommer K et al. Overexpression of the death-promoting gene bax-α which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J. Clin. Invest. 1996 97 : 2651 9.
25. Komatsu K, Suzuki S, Shimosegawa K et al. Cre-loxP mediated bax gene activation reduces cell growth and increases sensitivity to chemotherapeutic agents in human gastric cancer cells. Cancer Gene Ther. 2000 55 : 2111 15.
26. Schuler M, Maurer U, Goldstein JC et al. P53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ. 2003 10 : 451 60.
27. Scopa CD, Vagianos C, Kardamakis D, Kourelis TG, Kalofonos HP, Tsamandas AC. Bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer. Appl. Immunohistochem. Mol. Morphol. 2001 9 : 329 34.
28. Nakamura T, Nomura S, Skai T. Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their precursor lesions. Hum. Pathol. 1997 28 : 309 15.
29. Cho J-H, Kim WH. Altered topographic expression of p21/WAF1/CIP1/SDI1, bcl-2 and p53 during gastric carcinogenesis. Pathol. Res. Pract. 1998 194 : 309 17.
30. Gao HJ, Yu LZ, Bai JF et al. Multiple genetic alterations and behaviour of cellular biology in gastric cancer and other gastric mucosal lesions: H. pylori infection, histological type and staging. World J. Gastroenterol. 2000 6 : 848 54.
31. Kendler YM, Gabay G, Bernheim J et al. Expression of bcl-2 in autoimmune and Helicobacter pylori-associated atrophic gastritis. Dig. Dis. Sci. 1999 44 : 680 5.
32. Lauwers GY, Scott GV, Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 1994 73 : 2900 4.
33. Gil J, Yamamoto H, Zapata JM, Reed JC, Perucho M. Impairment of the proapoptotic activity of bax by missense mutations found in gastrointestinal cancers. Cancer Res. 1999 59 : 2034 7.
34. Rampino N, Yamamoto H, Ionov Y et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997 275 : 967 9.
35. Yamamoto H, Sawai H, Perucho M. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res. 1997 57 : 4420 6.
36. Ouyang H, Furukawa T, Abe T, Kato Y, Horii A. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium. Clin. Cancer Res. 1998 4 : 1071 4.
37. Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M. Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc. Natl. Acad. Sci. USA 2000 97 : 10872 7.
38. Yang Y, Deng CS, Peng JZ, Wong BC, Lam SK, Xia HH. Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells. Mol. Pathol. 2003 56 : 19 24.
39. Zhou HB, Zhu JR. Paclitaxel induces apoptosis in human gastric carcinoma cells. World J. Gastroenterol. 2003 9 : 442 5.
40. Nakata B, Muguruma K, Hirakawa K et al. Predictive value of Bcl-2 and Bax protein expression for chemotherapeutic effect in gastric cancer. A pilot study. Oncology 1998 55 : 543 7.
41. Mrozek A, Petrowsky H, Sturm I, Kraus J, Hermann S, Hauptmann S. Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability. Cell Death Differ. 2003 10 : 461 7.
42. Sawa H, Kobayashi T, Mukai K, Zhang W, Shiku H. Bax overexpression enhances cytochrome c release from mitochondria and sensitizes KATOIII gastric cancer cells to chemotherapeutic agent-induced apoptosis. Int. J. Oncol. 2000 16 : 745 9.
43. Kim R, Ohi Y, Inoue H, Toge T. Activation and the interaction of proapoptotic genes in modulating sensitivity to anticancer drugs in gastric cancer cells. Int. J. Oncol. 1999 15 : 751 6.